PARIS, France I June 10, 2025 I As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of ...

JUPITER, FL, USA I June 9, 2025 I Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular ...

DARMSTADT, Germany I June 09, 2025 I Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Center for Drug ...

MILAN, Italy I June 06, 2025 I Italfarmaco S.p.A. announced today that the European Commission (EC) has granted conditional marketing authorisation for ...

NEW YORK, NY, USA and SHANGHAI, China I June 09, 2025 I Medicovestor, Inc., a New York-based biotechnology company pioneering first-in-class ...

Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes.

Company to host conference call and webcast today at 8:00 A.M. ET ...

RENSSELAER, NY, USA I June 09, 2025 I Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license ...

Planning accelerated approval BLA submission in H2 2026, following topline data fromFORTITUDE™ biomarker cohort in Q2 2026 -- ...

BOSTON, MA, USA I June 09, 2025 I Anodyne Nanotech, a clinical-stage biotech company, today announced new preclinical data demonstrating that administration ...

Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome ...

INCHEON, Korea I June 09, 2025 I Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) announced today that the company has entered into a license, development and ...